Skip to main content
Log in

No Additive Effect Between Helicobacter pylori Infection and Portal Hypertensive Gastropathy on Inducible Nitric Oxide Synthase Expression in Gastric Mucosa of Cirrhotic Patients

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Increased expression of inducible nitric oxide synthase (iNOS) has been reported in gastric mucosa of patients with Helicobacter pylori infection or portal hypertensive gastropathy (PHG) but whether there is an additive or synergistic impact between H. pylori and PHG on iNOS expression was unknown. Sixty cirrhotic patients and 21 age-matched control subjects without liver disease were included. Biopsies from the gastric antrum and body were obtained for quantitative histological assessment and immunohistochemical staining for iNOS. iNOS staining was detected in endothelial cells and macrophages. In the absence of PHG, H. pylori significantly induced iNOS expression in cirrhotic patients. PHG also significantly induced iNOS expression in H. pylori-negative patients. However, there was no synergistic or additive effect between H. pylori and PHG on this expression. Furthermore, expression of iNOS was significantly higher in patients with severe PHG than in those with mild PHG and without PHG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Wallace JL, Miller MJS: Nitric oxide in mucosal defense: A little goes a long way. Gastroenterology 119:512-520, 2000

    Google Scholar 

  2. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell E, Mouvelle M, Moncade S: Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 18:1139-1143, 1993

    Google Scholar 

  3. Hori N, Okanoue T, Mori T, Kashima K, Nishimura M, Nanbu A, Yoshimura M, Takahashi H: Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis. Clin Exp Pharmacol Physiol 23:30-35, 1996

    Google Scholar 

  4. Ros J, Jimenez W, Lamas S, Claria J, Arroyo V, Rivera F, Rodes J: Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 21:554-560, 1995

    Google Scholar 

  5. Hori N, Wiest R, Groszmann RJ: Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology 28:1467-1473, 1998.

    Google Scholar 

  6. Kaviani A, OhtaM, Itani R, Sander F, Tarnawski AS, Safeh IJ: Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat. J Gastrointest Surg 1:371-376, 1997

    Google Scholar 

  7. Ohta M, Tanoue K, Tarnawski AS, Pai R, Itani RM, Sander FC, Sugimachi K, Sarfeh IJ: Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: a key to increased susceptibility to damage? Gastroenterology 112:1920-1930, 1997

    Google Scholar 

  8. Ohta M, Tarnawski AS, Itani R, Pai R, Tomikawa M, Sugimachi K, Sarfeh IJ: Tumor necrosis factor α regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats. Hepatology 27:906-913, 1998

    Google Scholar 

  9. El-Newihi HM, Kanji VA, Mihas AA: Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy. Am J Gastroenterol 91:535-538, 1996

    Google Scholar 

  10. Sumanovski LT, Battegay E, Stumm M, van der Kooij M, Sieber CC: Increased angiogenesis in portal hypertensive rats: role of nitric oxide. Hepatology 29:1044-1049, 1999

    Google Scholar 

  11. Blazer MJ: Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161:626-633, 1990

    Google Scholar 

  12. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication of Helicobacter pylori. Lancet 2:1437-1442, 1988

    Google Scholar 

  13. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori and the risk of gastric cancer. N Engl J Med 325:1127-1131, 1991

    Google Scholar 

  14. Wilson KT, Ramanujam KS, Mobley HLT, Musselman RF, James SP, Meltzer SJ: Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 111:1524-1533, 1196

    Google Scholar 

  15. Slomiany BL, Piotrowski J, Slomiany A: Induction of caspase-3 and nitric oxide synthase-2 during gastric mucosal inflammatory reaction to Helicobacter pylori lipopolysaccharide. Biochem Mol Biol Int 46:1063-1070, 1998

    Google Scholar 

  16. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P: Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 56:3238-3243, 1996

    Google Scholar 

  17. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT: Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116:1319-1329, 1999

    Google Scholar 

  18. Franco L, Talamini G, Carra G, Doria D: Expression of COX-1, COX-2, and inducible nitric oxide synthase protein in human gastric antrum with Helicobacter pylori infection. Prostaglandins Other Lipid Mediat 58:9-17, 1999

    Google Scholar 

  19. McCormick PA, Sankey EA, Cardin F, Dhillon AP, McIntvre N, Burroughs AK: Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study. Gut 32:351-354, 1991

    Google Scholar 

  20. Parikh SS, Desai SB, Prabhu SR, Trivedi MH, Shankaran K. Bhukanwala FA, Kalro RH, Desai HG: Congestive gastropathy: Factors influencing development, endoscopic features, Helicobacter pylori infection, and microvessel changes. Am J Gastroenterol 89:1036-1042, 1994

    Google Scholar 

  21. Balan KK, Jones AT, Roberts NB, Perason JP, Critchley M, Jenkins SA: The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol 91:1400-1406, 1996

    Google Scholar 

  22. Bahnacy A, Kupcsulik P, Eles Z, Jaray B, Flaunter L: Helicobacter pylori infection in congestive gastropathy. Helicobacter 1:168-171, 1996

    Google Scholar 

  23. de Franchis R: Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology, methodology and therapeutic strategies in portal hypertension. J Hepatol 33:846-852, 2000

    Google Scholar 

  24. Dixon MF, Genta RM, Yardly JH, Correa P: Classification and grading of gastritis. The Updated Sydney System. Am J Surg Pathol 20:1161-1181, 1996

    Google Scholar 

  25. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J: Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110:1744-1752, 1996

    Google Scholar 

  26. Tatemichi M, Ogura T, Nagata H, Esumi H: Enhanced expression of inducible nitric oxide synthase in chronic gastritis with intestinal metaplasia. J Clin Gastroenterol 27:240-245, 1998

    Google Scholar 

  27. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274, 1992

    Google Scholar 

  28. Lee FY, Lu RH, Tsai YT, Lin HC, Hou MC, Li CP, Liao TM, Lin LF, Wang SS, Lee SD: Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-α and hyperdynamic circulation. Scand J Gastroenterol 31:500-505, 1996

    Google Scholar 

  29. Gross SS, Jaffe EA, Levi R, Kilbourn RG: Cytokine-activated endothelial cells express an isotype of nitric oxide which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 178:823-829, 1991

    Google Scholar 

  30. Lin JY, Seguin R, Keller K, Chadee K: Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba hitolytica by enhanced expression of the nitric oxide synthase gene. Infect Immun 62:1534-1541, 1994

    Google Scholar 

  31. Farinati F, De Bona M, Floreani A, Foschia F, Rugge M: Helicobacter pylori and the liver: any relationship? Ital J Gastroenterol Hepatol 30:124-128, 1998

    Google Scholar 

  32. Lamarque D, Kiss J, Tankovic J, Fleiou JF, Delchier JC, Whittle BJ: Induction of nitric oxide synthase in vivo and cell injury in rat duodenal epithelium by a water soluble extract of Helicobacter pylori. Br J Pharmacol 123:1073-1078, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arafa, U.A., Fujiwara, Y., Higuchi, K. et al. No Additive Effect Between Helicobacter pylori Infection and Portal Hypertensive Gastropathy on Inducible Nitric Oxide Synthase Expression in Gastric Mucosa of Cirrhotic Patients. Dig Dis Sci 48, 162–168 (2003). https://doi.org/10.1023/A:1021707103590

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021707103590

Navigation